Value of tumor growth rate (TGR) as an early predictor of patients' outcome in patients diagnosed with well-differentiated neuroendocrine tumors (NETs): the GREPONET study.
Authors
Lamarca, AngelaCrona, J
Ronot, M
Opalinska, M
Lopez, C
Pezzutti, D
Najran, Pavan
Franca, R
Scaefer, N
Sundin, A
Pavel, M
Dromain, C
Affiliation
The Christie NHS FT, ManchesterIssue Date
2018